PGP and chronic myelogenous leukemia, BCR-ABL1 positive: The siP-gp delivered by drug-loaded delivery system (KNf-pV) with stimuli-responsive linker could significantly inhibit the expression of drug resistant-related P-gp, which consequently enhanced the chemosensitivity of CML cells in cancer therapy and reverse the drug resistance.